RICHMOND, Va., Dec. 12, 2018 /PRNewswire/ -- Kaléo, a privately-held pharmaceutical company, today announced that it will offer an authorized generic of its EVZIO® (naloxone HCl injection) take home ...

The Food and Drug Administration has approved an auto-injector developed by a Richmond pharmaceutical company for emergency treatment of an overdose involving powerful painkillers. EVZIO is a ...

(Reuters) - Kaleo Inc, which came under fire last year for the high price of its device to treat opioid overdoses, on Thursday said it is expanding nonprescription access to the Evzio injector and ...

In addition to the new authorized generic, Evzio is now available at $178 per carton (2 auto-injectors per carton) for government agencies, first responders, health departments, and other qualifying ...

After watching patients in need struggle to get access to naloxone, we made a commitment, starting in 2016, to make EVZIO® available for $0 out of pocket for all patients with commercial insurance and ...

First responders around the state will get a naloxone auto-injector aimed at stopping opioid overdoses under a grant announced Wednesday. But after the three-year grant from drugmaker Kaleo runs out, ...

While naloxone effectively reverses the effects of an opioid overdose, medical experts said the rising price of one form of the drug may limit overall access to the life-saving medicine. Opioid ...